Stock Scorecard

Stock Summary for Vir Biotechnology Inc (VIR) - $9.62 as of 12/9/2023 2:42:26 AM EST

Total Score

14 out of 29

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for VIR

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for VIR

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for VIR

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for VIR

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for VIR

It's Small Stocks' Time To Rally - Analysts Like These 11 Best 11/21/2023 1:00:00 PM
Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023 11/13/2023 10:40:00 PM
Softbank Vision Funds lose $3.86 billion in investments in H1 11/9/2023 8:30:00 PM
GSK Beats on Q3 Earnings and Sales, Raises 2023 Guidance 11/1/2023 3:21:00 PM
Dropbox handing over 25% of San Francisco HQ back to landlord as commercial real estate softens 10/20/2023 11:20:00 PM
HHS awards over $500 million to advance vaccines, therapeutics - .com 10/13/2023 6:55:00 PM
Vir Biotechnology to Participate in the H.C. Wainwright 4th Annual Hepatitis B Virus ( HBV ) Conference 10/12/2023 8:05:00 PM
Vir Biotechnology Announces Multiple Abstracts Highlighting New Chronic Hepatitis B and Hepatitis Delta Data Accepted for Presentation at AASLD's The Liver Meeting® 2023 10/11/2023 12:00:00 PM
Vir Biotechnology to Provide Business Update and Report Third Quarter 2023 Financial Results on November 2, 2023 - Vir Biotechnology ( NASDAQ:VIR ) 10/5/2023 8:30:00 PM
Vir Biotechnology to Provide Business Update and Report Third Quarter 2023 Financial Results on November 2, 2023 10/5/2023 8:30:00 PM

Financial Details for VIR

Company Overview
Ticker VIR
Company Name Vir Biotechnology Inc
Country USA
Description Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California.
Sector Name LIFE SCIENCES
Industry Name BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Most Recent Quarter 9/30/2023
Next Earnings Date 2/21/2024

Stock Price History
Last Day Price 9.62
Last Day Price Updated 12/9/2023 2:42:26 AM EST
Last Day Volume 0
Average Daily Volume N/A
52-Week High 31.55
52-Week Low 7.72
Last Price to 52 Week Low 24.61 %

Valuation Measures
Trailing PE N/A
Industry PE 158.38
Sector PE 62.37
5-Year Average PE 0.41
Free Cash Flow Ratio 0.76
Industry Free Cash Flow Ratio 17.89
Sector Free Cash Flow Ratio 31.15
Current Ratio Most Recent Quarter 10.72
Total Cash Per Share 12.64
Book Value Per Share Most Recent Quarter 12.45
Price to Book Ratio 0.77
Industry Price to Book Ratio 4.65
Sector Price to Book Ratio 19.59
Price to Sales Ratio Twelve Trailing Months 10.89
Industry Price to Sales Ratio Twelve Trailing Months 16.60
Sector Price to Sales Ratio Twelve Trailing Months 5.61

Share Statistics
Total Shares Outstanding 134,521,000
Market Capitalization 1,294,092,020
Institutional Ownership N/A

Dividends
Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Dividend King? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00 %
5-Year Dividend Payments Count 0
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 58.50 %
Annual Earnings Growth -2.41 %
Reported EPS 12 Trailing Months -4.50
Reported EPS Past Year -3.73
Reported EPS Prior Year 3.81
Net Income Twelve Trailing Months -600,747,000
Net Income Past Year 515,837,000
Net Income Prior Year 528,584,000
Quarterly Revenue Growth YOY -99.30 %
5-Year Revenue Growth 484.51 %

Balance Sheet
Total Cash Most Recent Quarter 1,700,000,000
Total Cash Past Year 2,400,000,000
Total Cash Prior Year 909,500,000
Net Cash Position Most Recent Quarter 1,700,000,000
Net Cash Position Past Year 2,400,000,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 2,077,963,000
Total Stockholder Equity Prior Year 1,431,849,000
Total Stockholder Equity Most Recent Quarter 1,675,085,000

Options
Put/Call Ratio 0.44
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD 0.16
MACD Signal 0.19
20-Day Bollinger Lower Band 6.53
20-Day Bollinger Middle Band 10.40
20-Day Bollinger Upper Band 14.27
Beta 0.38
RSI 53.38
50-Day SMA 19.43
200-Day SMA 31.67

System
Modified 12/10/2023 1:28:58 AM EST